Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Walgreens cutting 10% of corporate workforce
Moderna looks for opportunities in China after registering legal entity
*please scroll down for all the latest news*
